(4)in Article 16, point (b) is replaced by the following:
(b)MILK-RMP/NT drawn up in accordance with the model set out in Chapter 34 of Annex III, for dairy products intended for human consumption derived from raw milk or dairy products therefrom, or both, that are not required to undergo a specific risk-mitigating treatment;’;